Richard C Lauer MD

Oncology•Albuquerque, NM

Professor, Internal Medicine, University of New Mexico School of Medicine

Join to View Full Profile

1201 Camino de Salud NE# UnmAlbuquerque, NM 87102
Phone+1 505-272-4946
Fax+1 505-272-8060

Education & Training

Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1985 - 1988
Indiana University School of MedicineResidency, Internal Medicine, 1982 - 1985
New York Medical CollegeClass of 1982

Certifications & Licensure

IN State Medical License 1983 - 2025
NM State Medical License 2007 - 2025
GA State Medical License 1988 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2014

Clinical Trials

Functional Electrical Stimulation (FES) Cycling for Children With Spinal Cord Injuries (SCI) Start of enrollment: 2004 Mar 01
Completed
Not Applicable
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Start of enrollment: 2007 May 08
Active, not recruiting
Phase 3
The Effect of Botox on Children With Cerebral Palsy Start of enrollment: 2007 Jan 01
Completed
Wavelet Analysis of Electromyography (EMG) in Cerebral Palsy Start of enrollment: 2007 Mar 01
Completed
Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer Start of enrollment: 2008 Sep 01
Terminated
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma Start of enrollment: 2010 Apr 01
Terminated
Phase 2
S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy Start of enrollment: 2011 Aug 09
COMPLETED
PHASE2
Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer Start of enrollment: 2011 Jun 01
Withdrawn
Phase 2
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
ACTIVE_NOT_RECRUITING
PHASE3
Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer Start of enrollment: 2013 Jul 08
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts.
Richard C Lauer, Marc Barry, Tracey L Smith, Andrew Maltez Thomas, Jin Wu
Elife. 2023-01-16
2 citations
Improving Outpatient Infusion Clinic Wait Times at a Comprehensive Cancer Center.
Neda Hashemi-Sadraei, Shenthol Sasankan, Nick Crozier, Bernard Tawfik, Ronald Kittson
JCO Oncology Practice. 2021-06-17
1 citations
Pharmacist-Driven Oral Oncolytic Medication Education and Consent.
Harmony Bowles, Bernard Tawfik, Janet Abernathy, Richard C. Lauer, Neda Hashemi
JCO Oncology Practice. 2020-05-27

Press Mentions

Staying Home for TreatmentSeptember 10th, 2019
Clinical Trial for Personalized Kidney Cancer VaccineApril 20th, 2015
Clinical Trial Offers Patient ‘Best Shot’ at Fighting Kidney CancerApril 20th, 2015